VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MDXH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MDXHMDxHealth S.A.
$0.40$21M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMDXHBalance Sheet

MDxHealth S.A. (MDXH) Balance Sheet

22Y historyFree accessUpdated daily

The company's financial position is increasingly vulnerable, with total debt rising to $95.1 million by 2025Q4 and equity deteriorating into a negative $12.1 million balance.

MDXH Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04
Total Current Assets53.41M66.89M38.16M29.15M66.61M23.09M30.91M47.86M39.32M51.49M44.65M28.11M27.62M18.91M18.04M17.7M32.63M47.88M53.18M45.76M14.43M7.48M
Cash & Short-Term Investments29.03M46.8M22.38M15.6M58.59M15.95M22.1M26.2M16.83M30.51M30.52M18.9M24.68M15.49M14.42M14.09M25.84M42.6M48.26M43.3M11.16M310.43K
Cash Only29.03M46.8M22.38M15.5M58.5M15.95M22.05M26.2M16.83M30.51M30.52M18.9M24.68M15.49M14.42M14.09M25.84M42.6M48.26M43.3M11.16M310.43K
Short-Term Investments000101K89K051K000000000000000
Accounts Receivable14.68M14.53M11.27M9.36M4.58M3.89M6.64M19.13M19.93M18.54M11.21M7.99M2.36M2.69M3.32M3.07M4.59M3.87M0155.67K0706.27K
Days Sales Outstanding49.6558.958.6192.1775.276.99205.81246.42179.59226.51234.17254.16113.98200347.48332.47459.4335.6-15.54-490.12
Inventory6.74M3.87M2.78M2.33M1.91M2.32M1.19M1.81M1.92M1.48M1.43M860K171K122.99K00000000
Days Inventory Outstanding56.6540.4538.6247.6259.7481.4436.4756.668.6553.4375.4348.6410.7737.59--------
Other Current Assets2.96M135K146K151K504K52K54K104K24K-37K119K46K339K94K61K36.22K07562.88M1.32M1.26M5.26M
Total Non-Current Assets94.54M90.43M90.97M89.99M8.47M8.77M9.72M17.61M19.2M16.23M13.1M2.84M1.76M1.1M999.29K1.47M2.83M6.49M5M2.77M2.38M1.28M
Property, Plant & Equipment14.68M12.98M9.95M7.89M5.02M3.71M2.45M2.07M2.57M2.26M1.89M724K781K1.06M942.26K770.05K1.46M1.99M2.55M1.98M627.73K691.36K
Fixed Asset Turnover7.35x6.94x7.06x4.69x4.43x4.98x4.81x13.66x15.77x13.22x9.25x15.85x9.67x4.65x3.70x4.38x2.49x2.12x1.51x1.84x5.81x0.76x
Goodwill38.95M35.93M35.93M35.93M0001.15M1.15M1.15M1.15M00000000000
Intangible Assets39.42M40.59M44.34M46.17M3.45M5.06M7.27M14.39M15.49M12.83M10.03M2.01M981K37.03K57.03K62.51K70.2K2.29M106.43K227K320.97K521.91K
Long-Term Investments1.5M936K763K000000033K00000000000
Other Non-Current Assets000010000033K105K000642.37K1.3M2.21M2.34M564.88K1.43M67.78K
Total Assets147.95M157.33M129.13M119.14M75.07M31.86M40.63M65.48M58.52M67.72M57.74M30.95M29.38M20M19.04M19.18M35.46M54.36M58.18M48.54M16.81M8.76M
Asset Turnover0.73x0.57x0.54x0.31x0.30x0.58x0.29x0.43x0.69x0.44x0.30x0.37x0.26x0.25x0.18x0.18x0.10x0.08x0.07x0.08x0.22x0.06x
Asset Growth %-5.96%21.84%8.39%58.69%135.66%-21.59%-37.95%11.88%-13.59%17.28%86.55%5.34%46.91%5.04%-0.7%-45.93%-34.77%-6.56%19.87%188.76%91.8%-
Total Current Liabilities49.53M42.66M19.52M18.28M16.43M13.02M10.43M11.48M13.12M12.59M10.82M7.09M4.85M3.95M4.01M4.08M7.73M7.18M6.47M5.47M3.09M1.56M
Accounts Payable10.33M8M8.81M10.18M7.46M5.32M4.96M6.45M8.05M7.55M6.61M4.13M2.31M1.43M753.78K1.05M3.84M3.51M3.89M3.71M00
Days Payables Outstanding86.8183.66122.45208.3233.07186.42151.7202.14288.16272.62349.41233.38145.74436.4798.04775.385.47K3.79K2.16K18.68K--
Short-Term Debt1.9M324K643K616K4.44M2.82M565K147K191K430K440K001.43M0872.46K000000
Deferred Revenue (Current)00472K003.22M04.36M3.82M3.54M2.9M00-2.19M01.05M010000
Other Current Liabilities37.31M26.41M2.9M2.33M961K-2.31M909K402K883K1.08M975K1.14M958K-424.6K1.87M-546.61K2.22M945.23K2.58M1.75M1.92M491.97K
Current Ratio1.08x1.57x1.95x1.59x4.05x1.77x2.96x4.17x3.00x4.09x4.12x3.96x5.70x4.78x4.50x4.34x4.22x6.67x8.22x8.37x4.67x4.80x
Quick Ratio0.94x1.48x1.81x1.47x3.94x1.59x2.85x4.01x2.85x3.97x3.99x3.84x5.66x4.75x4.50x4.34x4.22x6.67x8.22x8.37x4.67x4.80x
Cash Conversion Cycle19.4915.7-25.22-68.5-98.12-27.9990.58100.89-39.927.33-39.8169.42-20.98-198.81--------
Total Non-Current Liabilities110.51M99.83M102.4M91.54M11.74M12.99M10.48M1.88M1.86M2.39M2.65M83K3.27M22.48K362.9K832.56K798.04K1.74M1.96M863.15K1.77M161.32K
Long-Term Debt84.71M50.97M35.56M34.91M7.65M10.28M9.05M0147K108K408K000207.37K0000000
Capital Lease Obligations8.51M7.41M3.58M3.09M2.62M2.02M735K262K376K0000002.66K001.46K2.64K5.92K16.27K
Deferred Tax Liabilities0000000575K616K729K842K0002.26M1.88M000000
Other Non-Current Liabilities17.3M41.45M63.26M53.54M1.47M690K690K1.04M661K1.55M1.39M83K000642.37K581.7K1.74M1.96M860.51K1.77M145.05K
Total Liabilities160.05M142.49M121.92M109.82M28.17M26.01M20.9M13.36M14.97M14.98M13.48M7.18M4.85M3.98M4.37M4.92M8.53M8.92M8.43M6.33M4.86M1.72M
Total Debt95.11M60.06M41.27M39.79M15.56M15.87M11M526K884K538K848K001.43M207.37K5.32K01.39K4.37K6.6K15.4K29.82K
Net Debt66.08M13.27M18.89M24.29M-42.94M-82K-11.05M-25.68M-15.94M-29.97M-29.67M-18.9M-24.68M-14.06M-14.21M-14.08M-25.84M-42.6M-48.26M-43.29M-11.14M-280.61K
Debt / Equity-4.05x5.72x4.27x0.33x2.71x0.56x0.01x0.02x0.01x0.02x--0.09x0.01x0.00x-0.00x0.00x0.00x0.00x0.00x
Debt / EBITDA----------------------
Net Debt / EBITDA----------------------
Interest Coverage-1.27x-3.94x-6.47x-15.06x-14.47x-17.70x-83.64x-395.23x-101.65x--143.53x-663.30x-803.55x-32.29x-115.52x-91.74x-714.07x-1131.52x-9.00x-8.53x-24.71x-33.56x
Total Equity-12.09M14.84M7.21M9.31M46.9M5.85M19.72M52.12M43.55M52.74M44.26M23.78M24.54M16.02M14.67M14.26M26.94M45.44M49.75M42.21M11.95M7.04M
Equity Growth %-181.49%105.9%-22.62%-80.14%701.83%-70.35%-62.15%19.68%-17.43%19.16%86.16%-3.1%53.12%9.22%2.88%-47.05%-40.73%-8.66%17.87%253.22%69.65%-
Book Value per Share-0.240.300.280.593.850.703.159.058.7211.4510.726.848.177.268.5310.8220.4438.3846.0449.2026.1518.77
Total Shareholders' Equity-12.09M14.84M7.21M9.31M46.9M5.85M19.72M52.12M43.55M52.74M44.26M23.78M24.54M16.02M14.67M14.26M26.94M45.44M49.75M42.21M11.95M7.04M
Common Stock219.21M214.67M173.93M148.42M143.42M76.72M70.72M53.88M45.95M45.85M42.79M37.83M35.48M25.33M18.16M13.99M73.2M70.98M66.31M53.62M27.48M19.25M
Retained Earnings-403.03M-369.51M-331.45M-288.35M-244.3M-215.3M-186.64M-143.54M-111.09M-98.8M-85.63M-71.15M-55.82M-38.02M-25.63M-17.06M-64.68M-14.19M-30.11M-14.09M-16.02M-12.53M
Treasury Stock0000000000000000000000
Accumulated OCI18.55M-615K11.55M-3.94M-5.39M8.08M-704K-1.17M1.24M-686K-722K-433K-683K-76.7K00000000
Minority Interest0000000000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and solvency pressure

Eroding Equity and Rising Liabilities

As reported in recent financial statements, MDXH's equity position has deteriorated into a negative $12.1 million balance by 2025Q4, driven by the accumulation of $403 million in retained losses that significantly outpace the company's ability to generate organic capital through its diagnostic service operations.

The shift from positive equity in previous periods to a deficit indicates that the company is effectively operating on borrowed capital and external funding. This trajectory suggests that the business model has yet to achieve the scale necessary to offset its historical losses, leaving the balance sheet in a precarious state.

Leverage Burdening Future Cash Flows

Based on MDXH's reported figures, total debt has climbed to $95.1 million as of 2025Q4, representing a substantial increase from the $15.1 million observed in 2021Q2, which underscores a growing reliance on debt financing to sustain operations in the absence of consistent positive free cash flow.

The rising debt load relative to the company's limited asset base suggests that interest obligations may increasingly constrain the capital available for commercial expansion. Investors should monitor whether this leverage is being used to fund high-return growth initiatives or merely to bridge the gap created by persistent operating losses.

Tightening Runway Amidst Operational Burn

According to recent SEC filings, MDXH's current ratio has compressed to 1.08 in 2025Q4, down from a peak of 4.05 in 2021Q4, signaling a narrowing buffer against short-term liquidity shocks as cash reserves dwindle to $29 million against a backdrop of ongoing operational cash outflows.

A current ratio hovering near parity suggests that the company has minimal room for error in its working capital management. Any delay in reimbursement collections or unexpected spikes in operating costs could force the company to seek dilutive financing or further debt, potentially impacting shareholder value.

Goodwill Impairment and Asset Quality

As indicated by the latest balance sheet data, goodwill has risen to $38.9 million, representing over 26% of total assets, which warrants further investigation into the carrying value of acquired diagnostic assets relative to their actual contribution to current revenue streams and long-term profitability.

The concentration of intangible assets on the balance sheet creates a risk of future impairment charges if the acquired technologies fail to meet projected commercial adoption targets. This reliance on goodwill to support the asset base may mask the underlying weakness in the company's tangible asset productivity.

MDXH — Frequently Asked Questions

Quick answers to the most common questions about buying MDXH stock.

What are the total assets of MDxHealth S.A. (MDXH)?

As of 2025, MDxHealth S.A. (MDXH) had total assets of $148.0M including $53.4M in current assets.

How much debt does MDxHealth S.A. (MDXH) have?

MDxHealth S.A. (MDXH) carries total debt of $95.1M, offset by $29.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of MDxHealth S.A.?

MDxHealth S.A. (MDXH) has total shareholders' equity (book value) of $-12.1M ($-0.24 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is MDxHealth S.A.'s current ratio and liquidity?

MDxHealth S.A. (MDXH) reported a current ratio of 1.08x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.